Global Chronic Pain Treatment Market Projected to Expand at 9.2% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Chronic Pain Treatment Market Expected To Become By 2029 Compared With Its 2025 Level?

The chronic pain treatment market size has demonstrated substantial expansion in recent years. This market is expected to increase from $99.64 billion in 2024 to $109.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. During prior periods, this growth was primarily influenced by an aging population, a rising incidence of chronic diseases, enhanced awareness concerning pain management, an increase in the use of prescription opioids, and broader health insurance coverage.

The chronic pain treatment market is projected to experience substantial expansion in the coming years. This market is set to reach $155 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by factors such as a move towards non-opioid alternatives, greater government funding for pain research, an increasing demand for personalized medicine, the growing adoption of digital pain management tools, and the expanded application of AI for pain diagnosis and treatment planning. Key trends anticipated within the forecast timeframe encompass advancements in neuromodulation therapies, the integration of telemedicine into pain care, the development of cannabinoid-based therapies, an emphasis on multidisciplinary treatment approaches, and an increase in wearable pain monitoring devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Are The Key Drivers Of Growth In The Chronic Pain Treatment Market?

An anticipated increase in arthritis pain is projected to fuel the expansion of the chronic pain treatment market in the future. Arthritis pain is defined as the unpleasant sensation, throbbing, or tenderness experienced in joints, resulting from inflammation or deterioration stemming from arthritis. This increasing occurrence of arthritis pain is predominantly fueled by an aging demographic, given that the natural wear and tear on joints escalates with age, culminating in a higher frequency of conditions linked to arthritis. Treatment for chronic pain addresses arthritis pain by focusing on reducing inflammation and nerve sensitivity, thereby alleviating discomfort, enhancing joint mobility, and elevating the overall quality of life for those experiencing ongoing arthritis symptoms. As an illustration, data from March 2023, provided by the Office for Health Improvement and Disparities, a UK-based government entity, indicated that in 2022, 17.6% of persons aged 16 and older reported experiencing a long-term musculoskeletal (MSK) condition, including arthritis or continuous issues with their back or joints; this figure shows a rise from 17.0% recorded in 2021. Consequently, the growing incidence of arthritis pain is stimulating the expansion of the chronic pain treatment market.

Which Key Segments Fueling The Chronic Pain Treatment Market?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Trends Are Redefining The Chronic Pain Treatment Market Dynamics?

Key players in the chronic pain treatment market are concentrating on creating cutting-edge products like rechargeable spinal cord stimulators to increase patient convenience and optimize long-term pain management results. A rechargeable spinal cord stimulator is a medical apparatus surgically placed near the spine that emits electrical pulses to inhibit pain signals, and it can be replenished externally without needing an operation. It assists in managing chronic pain by disrupting the pain pathways within the spinal cord, thereby lowering the perception of pain for patients suffering from conditions such as failed back surgery syndrome or neuropathic pain. As an illustration, in December 2022, Abbott Laboratories, a US-based medical device company, unveiled the Eterna spinal cord stimulation system. Being more compact than an Apple AirPods case, the Eterna device is exceptionally small and inconspicuous, presenting a user-friendly answer for addressing chronic pain. It delivers considerable pain alleviation, has shown the capacity to lessen reliance on opioid medications, and is engineered for extended, minimally invasive deployment, consequently boosting patients’ daily functionality and their overall quality of life.

Which Global Market Leaders Are Shaping The Future Of The Chronic Pain Treatment Sector?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

What Regional Growth Trends Are Shaping The Chronic Pain Treatment Market Outlook?

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2025, By The Business Research Company

Chronic Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795